arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

VERACYTE, INC.

VCYT
$47.21 ▲ +1.08 (+2.34%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
58 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
67
Health
Good
Neutral
auto_awesome

Analytical Summary

VERACYTE, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $3.8B
Dividend Yield
Revenue Growth 15.5%
Op. Margin 15.3%
ROIC 1.6%
FCF / Share $0.54
Trailing P/E 147.5x
Price / Book 2.7x
FCF Yield 1.1%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

58-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$150.32M
↑ +15.5%
Net Income Profit after all expenses
$25.49M
↓ -11.2%
Operating Margin Operating profit as % of sales
15.3%
↓ -6.1% 59th
FCF / Share Free cash flow per share
$0.54
↑ +32.5%
Long-Term Debt Long-term obligations
$1.07M
↑ +17.2%

Health Breakdown

Profitability
72
Returns
54
Cash Quality
85

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 58 quarters